US – India-based pharmaceutical company Granules India has revealed plans to develop a US$12.5 million pharmaceutical packaging facility in Virginia, US.
The new facility will be part of the company’s Consumer Health division and will return previously outsourced services in-house.
Granules will lease 79,000 square feet of the Parkway 66 property at 7413 Cushing Road in Manassas and build out packaging lines and clean rooms to package and ship pharmaceuticals.
Granules India founder and managing director Dr. Krishna Prasad Chigurupati said: “The addition of a US packaging facility will result in Granules being among the few pharmaceutical companies to be vertically integrated from API to packaging, which will bolster the robustness of Granules’ supply chain while also enabling the company to react even faster to consumers’ growing needs for pharmaceutical products.
“The company chose Virginia because of Prince William County’s responsiveness, which allowed Granules faster access to commercialization.
“In addition, Prince William offers a dynamic and diverse workforce that is eager to work along with the site’s proximity to several major seaports
Granules India currently has another pharmaceutical research and development and manufacturing facility in Fairfax County, Virginia, which employs 130 colleagues.
The company’s new facility will create 57 jobs and has received a US$200,000 grant from the Commonwealth’s Opportunity Fund.
Governor Youngkin said: “Virginia continues to attract pharmaceutical manufacturing, and Granules India’s new packaging operation in Prince William County is an important addition to the pharmaceutical ecosystem in the Commonwealth.
“The company’s decision to expand its footprint in Virginia is a testament to our infrastructure and robust workforce, and we look forward to further development of this partnership.”
Caren Merrick, Secretary of Commerce and Trade, Commonwealth of Virginia added: “When a global company like Granules India establishes a second Virginia operation, it reinforces our business-friendly climate, collaborative environment, and skilled workforce.”
Based in Hyderabad, India, Granules India manufactures active pharmaceutical ingredients and other related products, including acetaminophen, ibuprofen and guaifenesin, the main ingredient in Mucinex.
The company serves brand and generic drug companies in more than 75 countries and has eight manufacturing facilities around the world.
For all the latest packaging and printing industry news from Africa and the World, subscribe to our NEWSLETTER, follow us on Twitter and LinkedIn, like us on Facebook, and subscribe to our YouTube channel.
